Literature DB >> 17972053

Combination of the C1429T polymorphism in the G-protein beta-3 subunit gene and the A1330V polymorphism in the low-density lipoprotein receptor-related protein 5 gene is a risk factor for hypercholesterolaemia.

Y Suwazono1, E Kobayashi, M Dochi, K Miura, Y Morikawa, M Ishizaki, T Kido, H Nakagawa, K Nogawa.   

Abstract

The present study examined the relationship between genetic combinations of the C1429T polymorphism in the G-protein beta-3 subunit (GNB3) gene and the A1330V polymorphism in the low-density lipoprotein receptor-related protein 5 (LRP5) gene and the risk of hypercholesterolaemia in Japanese workers. The present study included observations from 1997 to 2002 in 927 males and 662 females who were not hypercholesterolaemic on entry. The endpoint was the development of hypercholesterolaemia, defined as a total cholesterol level > or =240 mg/dl. The odds ratios for the combination of polymorphisms were calculated using pooled logistic regression analyses that incorporated other potential factors into the model. The odds ratios in males and females with GNB3/1429TT and LRP5/1330VV or AV genotypes were 4.17 compared to males with the 1429CT or TT and 1330AA genotypes and 3.53 compared to females with the 1429CC, CT or TT and 1330AA genotypes. Assuming these effects were a mere addition of two independent effects, the odds ratios for both GNB3/1429TT and LRP5/1330VV or AV were estimated to be 3.27 for males and 1.42 for females. Therefore, the synergic effects were shown to be 1.28 times in males (not significant) and 2.49 times in females (P<0.05 by bootstrap method). These results provide clear evidence that the genetic combination has a synergic effect. This study indicates that the combination of GNB3/C1429T and LRP5/A1330V is a very useful marker for predicting the development of hypercholesterolaemia in the general Japanese population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17972053     DOI: 10.1007/s10238-007-0131-1

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  35 in total

1.  Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study.

Authors:  R B D'Agostino; M L Lee; A J Belanger; L A Cupples; K Anderson; W B Kannel
Journal:  Stat Med       Date:  1990-12       Impact factor: 2.373

2.  Linkage and association mapping of the LRP5 locus on chromosome 11q13 in type 1 diabetes.

Authors:  Rebecca C J Twells; Charles A Mein; Felicity Payne; Riitta Veijola; Matthew Gilbey; Matthew Bright; Andrew Timms; Yusuke Nakagawa; Hywel Snook; Sarah Nutland; Helen E Rance; Philippa Carr; Frank Dudbridge; Heather J Cordell; Jason Cooper; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Michael Phillips; Michael Metzker; J Fred Hess; John A Todd
Journal:  Hum Genet       Date:  2003-04-17       Impact factor: 4.132

3.  Cloning of a novel member of the low-density lipoprotein receptor family.

Authors:  P J Hey; R C Twells; M S Phillips; S D Brown; Y Kawaguchi; R Cox; V Dugan; H Hammond; M L Metzker; J A Todd; J F Hess
Journal:  Gene       Date:  1998-08-17       Impact factor: 3.688

4.  Low-density-lipoprotein-receptor-related protein (LRP) interacts with a GTP-binding protein.

Authors:  L Goretzki; B M Mueller
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

5.  Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density.

Authors:  Liesbeth Van Wesenbeeck; Erna Cleiren; Jeppe Gram; Rodney K Beals; Olivier Bénichou; Domenico Scopelliti; Lyndon Key; Tara Renton; Cindy Bartels; Yaoqin Gong; Matthew L Warman; Marie-Christine De Vernejoul; Jens Bollerslev; Wim Van Hul
Journal:  Am J Hum Genet       Date:  2003-02-10       Impact factor: 11.025

6.  Haplotype structure, LD blocks, and uneven recombination within the LRP5 gene.

Authors:  Rebecca C J Twells; Charles A Mein; Michael S Phillips; J Fred Hess; Riitta Veijola; Matthew Gilbey; Matthew Bright; Michael Metzker; Benedicte A Lie; Amanda Kingsnorth; Edward Gregory; Yusuke Nakagawa; Hywel Snook; William Y S Wang; Jennifer Masters; Gillian Johnson; Iain Eaves; Joanna M M Howson; David Clayton; Heather J Cordell; Sarah Nutland; Helen Rance; Philippa Carr; John A Todd
Journal:  Genome Res       Date:  2003-05       Impact factor: 9.043

7.  A new low density lipoprotein receptor related protein, LRP5, is expressed in hepatocytes and adrenal cortex, and recognizes apolipoprotein E.

Authors:  D H Kim; Y Inagaki; T Suzuki; R X Ioka; S Z Yoshioka; K Magoori; M J Kang; Y Cho; A Z Nakano; Q Liu; T Fujino; H Suzuki; H Sasano; T T Yamamoto
Journal:  J Biochem       Date:  1998-12-01       Impact factor: 3.387

8.  Transforming growth factor-beta up-regulates low density lipoprotein receptor-mediated cholesterol metabolism in vascular smooth muscle cells.

Authors:  A C Nicholson; D P Hajjar
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

9.  Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion.

Authors:  Takahiro Fujino; Hiroshi Asaba; Man-Jong Kang; Yukio Ikeda; Hideyuki Sone; Shinji Takada; Dong-Ho Kim; Ryoichi X Ioka; Masao Ono; Hiroko Tomoyori; Minoru Okubo; Toshio Murase; Akihisa Kamataki; Joji Yamamoto; Kenta Magoori; Sadao Takahashi; Yoshiharu Miyamoto; Hisashi Oishi; Masato Nose; Mitsuyo Okazaki; Shinichi Usui; Katsumi Imaizumi; Masashi Yanagisawa; Juro Sakai; Tokuo T Yamamoto
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-30       Impact factor: 11.205

10.  Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E.

Authors:  Kenta Magoori; Man-Jong Kang; Mitsuko R Ito; Hajime Kakuuchi; Ryoichi X Ioka; Akihisa Kamataki; Dong-Ho Kim; Hiroshi Asaba; Satoshi Iwasaki; Yumiko A Takei; Masako Sasaki; Shinichi Usui; Mitsuyo Okazaki; Sadao Takahashi; Masao Ono; Masato Nose; Juro Sakai; Takahiro Fujino; Tokuo T Yamamoto
Journal:  J Biol Chem       Date:  2002-12-31       Impact factor: 5.157

View more
  3 in total

1.  Lack of Lrp5 Signaling in Osteoblasts Sensitizes Male Mice to Diet-Induced Disturbances in Glucose Metabolism.

Authors:  Soohyun P Kim; Julie L Frey; Zhu Li; Brian C Goh; Ryan C Riddle
Journal:  Endocrinology       Date:  2017-11-01       Impact factor: 4.736

Review 2.  Bone and the regulation of global energy balance.

Authors:  Q Zhang; R C Riddle; T L Clemens
Journal:  J Intern Med       Date:  2015-06       Impact factor: 8.989

Review 3.  Regulation of Osteoblast Metabolism by Wnt Signaling.

Authors:  Megan C Moorer; Ryan C Riddle
Journal:  Endocrinol Metab (Seoul)       Date:  2018-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.